Review of Foreign Investment in U.S. Pharmaceutical Industry
This act requires the government to annually report on the impact of foreign investment on drug production in the U.S. The goal is to understand if America is sufficiently self-reliant in producing medicines and their ingredients, which could affect drug availability and prices for citizens.
Key points
The government will study how foreign investments affect the U.S.'s ability to produce drugs independently.
Reports will assess whether over-reliance on foreign drug manufacturers poses risks to public health.
Information from the reports will be publicly available, increasing transparency in the pharmaceutical sector.
Expired
Citizen Poll